Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition

Kathryn E. Bradbury, Paul N. Appleby, Sarah J. Tipper, Ruth C. Travis, Naomi E. Allen, Marina Kvaskoff, Kim Overvad, Anne Tjonneland, Jytte Halkjaer, Iris Cervenka, Yahya Mahamat-Saleh, Fabrice Bonnet, Rudolf Kaaks, Renee T. Fortner, Heiner Boeing, Antonia Trichopoulou, Carlo La Vecchia, Alexander J. Stratigos, Domenico Palli, Sara GrioniGiuseppe Matullo, Salvatore Panico, Rosario Tumino, Petra H. Peeters, H. Bas Bueno-de-Mesquita, Reza Ghiasvand, Marit B. Veierod, Elisabete Weiderpass, Catalina Bonet, Elena Molina, Jose M. Huerta, Nerea Larranaga, Aurelio Barricarte, Susana Merino, Karolin Isaksson, Tanja Stocks, Ingrid Ljuslinder, Oskar Hemmingsson, Nick Wareham, Kay-Tee Khaw, Marc J. Gunter, Sabina Rinaldi, Konstantinos K. Tsilidis, Dagfinn Aune, Elio Riboli, Timothy J. Key

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalInternational Journal of Cancer
Volume144
Issue number5
Pages (from-to)957-966
Number of pages10
ISSN0020-7136
DOIs
Publication statusPublished - 1 Mar 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • melanoma
  • insulin-like growth factor I
  • height
  • EPIC
  • biomarker
  • prospective studies
  • CUTANEOUS MELANOMA
  • IGF-I
  • METAANALYSIS
  • INDEX
  • CELLS
  • 3122 Cancers

Cite this